TELA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TELA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
TELA Bio's change in inventory for the quarter that ended in Dec. 2023 was $0.79 Mil. It means TELA Bio's inventory declined by $0.79 Mil from Sep. 2023 to Dec. 2023 .
TELA Bio's change in inventory for the fiscal year that ended in Dec. 2023 was $-2.72 Mil. It means TELA Bio's inventory increased by $2.72 Mil from Dec. 2022 to Dec. 2023 .
TELA Bio's Total Inventories for the quarter that ended in Dec. 2023 was $13.16 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. TELA Bio's Days Inventory for the quarter that ended in Dec. 2023 was 233.35.
Inventory Turnover measures how fast the company turns over its inventory within a year. TELA Bio's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.39.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. TELA Bio's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.81.
The historical data trend for TELA Bio's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELA Bio Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Change In Inventory | Get a 7-Day Free Trial | -1.84 | -0.62 | -5.19 | -6.07 | -2.72 |
TELA Bio Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Change In Inventory | Get a 7-Day Free Trial | 0.47 | -3.86 | 0.92 | -0.57 | 0.79 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELA Bio (NAS:TELA) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
TELA Bio's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 13.7425 | / | 5.374 | * | 365 / 4 | |
= | 233.35 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
TELA Bio's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 5.374 | / | 13.7425 | |
= | 0.39 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TELA Bio's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 13.7425 | / | 16.998 | |
= | 0.81 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of TELA Bio's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Gregory A. Firestone | officer: Chief Business Officer | C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN PA 19355 |
Roberto Cuca | officer: COO and CFO | C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406 |
Antony Koblish | director, officer: Chief Executive Officer | C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN PA 19355 |
Orbimed Advisors Llc | 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Orbimed Capital Gp Iv Llc | 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Opaleye Management Inc. | 10 percent owner | ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108 |
Ew Healthcare Partners Fund 2-a, L.p. | other: See footnotes 1 and 2 | 280 PARK AVENUE, 27TH FLOOR EAST, NEW YORK NY 10017 |
Quaker Bioventures Ii Lp | 10 percent owner | QUAKER BIOVENTURES, 2929 ARCH STREET, PHILADELPHIA PA 19104 |
Quaker Bioventures Capital Ii, L.p. | 10 percent owner | CIRA CENTER, 2929 ARCH STREET, PHILADELPHIA PA 19104 |
Lisa N Colleran | director | 0NE MILLENIUM WAY, BRANCHBURG NJ 08876 |
John Nosenzo | director | C/O BIOVENTUS INC., 4721 EMPEROR BOULEVARD, SUITE 400, DURHAM NC 27703 |
Federica F. O'brien | director | C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN PA 19355 |
Kurt Azarbarzin | director | C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN PA 19355 |
Vincent J Burgess | director | 2210 FARADAY AVE #100, CARLSBAD CA 92008 |
Douglas G Evans | director | 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN PA 19355 |
From GuruFocus
By sperokesalga sperokesalga • 05-02-2023
By Stock market mentor Stock market mentor • 01-09-2023
By Stock market mentor Stock market mentor • 01-20-2023
By sperokesalga sperokesalga • 02-28-2023
By Marketwired • 09-18-2023
By Marketwired • 08-04-2023
By sperokesalga sperokesalga • 04-18-2023
By sperokesalga sperokesalga • 02-21-2023
By Marketwired • 07-26-2023
By Marketwired • 10-26-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.